Anti-Human IGLL1 Therapeutic Antibody

Recombinant Human monoclonal antibody expressed in CHO binding to Human IGLL1. This is an antibody having immunoreactivity to a polypeptide comprising not less than 7 continuous amino acids in the CD179b protein, which was identified as a cancer antigen protein specifically expressed on the surfaces of cancer cells, can be used as a pharmaceutical composition for therapy and/or prophylaxis of cancer.
Supplier Creative Biolabs
Product # TAB-389CL
Pricing Inquiry
Host Human
Target IGLL1
Species Reactivity Human
Type Antibody
Storage ≤1 year at -20°C.
Feedback